Company / Current Liabilities per Share
X4 Pharmaceuticals, Inc Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.52
FY2025
5-year range
$0.20 / $4.52
FY2021-FY2025
Trend
+2202.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +2202% YoY in FY2025, a notable deviation from the 5-year average annual change of +446%.
Based on SEC 10-K filings.
4.52 in FY2025 with a 5-year CAGR of +43.6%.
Increased from $0.79 to $4.52 over the past 3 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +78.6%
- 5-Year CAGR
- +43.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 2202.0% year-over-year.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.52 | +2202.0% |
| FY2024 | $0.20 | -75.3% |
| FY2022 | $0.79 | -7.7% |
| FY2021 | $0.86 | +16.1% |
| FY2020 | $0.74 | +96.2% |
| FY2018 | $0.38 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026